Table 1.

Viability percentage in TM3 cells at different doses and duration times of TAU treatment (pilot study).

Treatments	12 h	24 h	48	72
12.5µg/mL	99.4 ± 4.5	98.7 ± 4.7	98.6 ± 2.2	100.4 ± 3.2
25 µg/mL	98.3 ± 4.8	101.5 ± 3.2	102.2 ± 5.3	102.6 ± 5.1
50 µg/mL	99.2 ± 3.5	105.7 ± 6.9	105.6 ± 4.2	104.3 ± 6.4
100 µg/mL	98.6 ± 5.5	135.2 ± 11.2*	138.1 ± 9.3*	132.8 ± 9.8*
150 µg/mL	98.8 ± 4.3	136.4 ± 12.2*	137.3 ± 10.7*	134.6 ± 12.3*
200 µg/mL	99.2 ± 3.6	136.7 ± 10.7*	137.8 ± 11.3*	135.1 ± 10.7*

Values are expressed as mean ± SD (n=6).

^*p<0.05 *symbol indicates comparison to 12h in each row